Literature DB >> 17887917

Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?

Michelangelo Mancuso1, Fabio Coppedè, Luigi Murri, Gabriele Siciliano.   

Abstract

Mitochondria are recognized to play a pivotal role in neuronal cell survival or death because they are regulators of both energy metabolism and apoptotic pathways. Morphologic, biochemical, and molecular genetic studies suggest that mitochondria might be a convergence point for neurodegeneration, including Alzheimer's disease (AD). The functions and properties of mitochondria might render subsets of selectively vulnerable neurons intrinsically susceptible to cellular aging and stress. However, the question, "Is mitochondrial dysfunction a necessary step in neurodegeneration?" is still unanswered. This review presents the ways in which malfunctioning mitochondria and oxidative stress might contribute to neuronal death in AD.

Entities:  

Mesh:

Year:  2007        PMID: 17887917     DOI: 10.1089/ars.2007.1761

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  23 in total

Review 1.  Transdermal delivery of treatment for Alzheimer's disease: development, clinical performance and future prospects.

Authors:  Agnes L F Chan; Yie W Chien; Shun Jin Lin
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

2.  Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Mubeen A Ansari; Kelly N Roberts; Frederick A Schmitt; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 3.  Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2011-08-18

Review 4.  Genome instability in Alzheimer disease.

Authors:  Yujun Hou; Hyundong Song; Deborah L Croteau; Mansour Akbari; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2016-04-20       Impact factor: 5.432

5.  Mitochondrial toxic effects of Aβ through mitofusins in the early pathogenesis of Alzheimer's disease.

Authors:  Zhaofei Wu; Yushan Zhu; Xingshui Cao; Shufeng Sun; Baolu Zhao
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

6.  Brain mitochondrial dysfunction in ovariectomized mice injected with D-galactose.

Authors:  Yang Su; Hao Sun; Jie Fang; Gang Hu; Ming Xiao
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

7.  Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.

Authors:  Antonella Bobba; Vito A Petragallo; Ersilia Marra; Anna Atlante
Journal:  Int J Alzheimers Dis       Date:  2010-09-02

Review 8.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

9.  Clinic and genetic evaluation of variegate porphyria (VP) in a large family from the Balearic Islands.

Authors:  A Bonnin; A Picornell; J Orfila; J A Castro; M M Ramon
Journal:  J Inherit Metab Dis       Date:  2009-02-20       Impact factor: 4.982

10.  The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.

Authors:  Erez Podoly; Deborah E Shalev; Shani Shenhar-Tsarfaty; Estelle R Bennett; Einor Ben Assayag; Harvey Wilgus; Oded Livnah; Hermona Soreq
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.